Table 2. Prevalence of demographic/behavioural risk factors in women with positive and negative HIV test results.

Demographic or Risk Behaviour	HIV+/total 18/2535	Early Test HIV- n = 2517	Early Test HIV + n = 18	p
Race/Ethnicity	18/2425			0.008*
White non-Hispanic		953 (39.6%)	2 (11.8%)
Hispanic/Latino		867 (36.0%)	14 (82.4%)
Black non-Hispanic		284 (11.8%)	1 (5.9%)
Asian		125 (5.2%)	0 (0%)
Other		179 (7.4%)	0 (0%)
Age	18/2535			0.368
≤24 years		560 (22.2%)	2 (11.1%)
25–49 years		1642 (65.2%)	15 (83.3%)
≥50 years		315 (12.5%)	1 (5.6%)
Previous HIV test	17/2197	1999 (91.7%)	15 (88.2%)	0.647
Months since last HIV test (median, IQR)	15/1919	9.4 (3.3–26.0)	1.3 (0.48–12.4)	0.018*
Number of partners, prior 12 months (median, IQR)	18/2476	2 (1–3)	1 (1–2)	0.111
One or fewer partners in prior 12 months	18/2476	1093 (44.5%)	12 (66.7%)	0.093#
Sex with MSM, 12 months	15/2047	156 (7.7%)	1 (6.7%)	1
Sex with injection drug user, 12 months	18/2472	263 (10.7%)	3 (16.7%)	0.433
Sex with HIV-infected partner, 12 months	18/2461	188 (7.7%)	6 (33.3%)	0.002*
Sex in exchange for money or drugs, 12 months	11/1348	28 (2.1%)	0 (0%)	1.000
Unprotected Receptive Anal Intercourse	18/2387	221 (9.3%)	2 (11.1%)	0.682
Unprotected Vaginal Intercourse	17/2186	1835 (84.6%)	14 (82.4%)	0.737
Other sexually transmitted infection (STI)
Any STI, 12 months	17/2477	203 (8.3%)	4 (23.5%)	0.047*
Bacterial STI, 12 months	17/2477	106 (4.3%)	2 (11.8%)	0.168
Any STI ever	17/2438	413 (17.1%)	3 (17.6%)	1.000
Drug Use
Injection Drug Use, 12 months	18/2513	152 (6.1%)	2 (11.1%)	0.303
Use of stimulants, 12 months¥	18/2513	608 (24.4%)	3 (16.7%)	0.587

^*Statistically significant p < 0.05.

^#Trend that approaches statistical significance.

^¥Stimulants: methamphetamine, cocaine, crack, GHB, ecstasy, ketamine; IQR = interquartile ratio.